Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

This study is currently recruiting participants.
Verified January 2012 by University of Cincinnati
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Oliver Rixe, University of Cincinnati
ClinicalTrials.gov Identifier:
NCT01508104
First received: January 6, 2012
Last updated: NA
Last verified: January 2012
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)